High-dose flu vaccine may improve seroprotection in HIV patients

01/3/2013 | MedPage Today (free registration)

Researchers studied 190 HIV patients and found that those who received four times the standard dose of influenza vaccine showed greater seroprotection against the flu than those who received normal doses. "For every antigen studied, the high-dose formulation resulted in an increased average antibody titer and higher seroconversion and seroprotective rates compared with the standard-dose influenza vaccine," according to the study in Annals of Internal Medicine.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL